SCHEMBL27811642

SCHEMBL27811642

[CH2]Cc1c(Cl)nc(N)nc1N(C)c1nn(CC)cc1Cl

nearest known ligand 0.32

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 2/20 0.32
ADORA1 P30542 2/20 0.32
KDM4E B2RXH2 1/20 0.30
HPGD P15428 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27811592 0.65 KDM4E (0.38) ADORA2AADORA1KDM4EHPGDSMN1; SMN2
SCHEMBL28787791 0.59 KCNH2 (0.32)
SCHEMBL20377491 0.59
SCHEMBL12495474 0.57 SMN1; SMN2 (0.46) ADORA2AADORA1KDM4EHPGDSMN1; SMN2
SCHEMBL25423635 0.57
SCHEMBL13440864 0.57
SCHEMBL17863738 0.57
SCHEMBL29951802 0.56 SMN1; SMN2 (0.40) KDM4EHPGDSMN1; SMN2RAB9A
SCHEMBL13255976 0.56 RAB9A (0.35) KDM4ESMN1; SMN2RAB9A
SCHEMBL1078235 0.56 L3MBTL1 (0.37) ADORA2AADORA1KDM4ESMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102098918-A Bioactive compounds for treatment of cancer and neurodegenerative diseases PONIARD PHARMACEUTICALS INC 2011-06-15 CN disclosed